WallStSmart
SYK

Stryker Corporation

NYSE: SYK · HEALTHCARE · MEDICAL DEVICES

$312.20
+2.15% today

Updated 2026-06-12

Market cap
$112.44B
P/E ratio
33.91
P/S ratio
4.45x
EPS (TTM)
$8.65
Dividend yield
1.15%
52W range
$281 – $402
Volume
2.5M

Stryker Corporation (SYK) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$5.41B$6.00B$6.72B$6.72B$7.32B$8.31B$8.66B$9.02B$9.68B$9.95B$11.32B$12.44B$13.60B$14.88B$14.35B$17.11B$18.45B$20.50B$22.59B$25.12B
Revenue growth (YoY)+11.0%+12.0%+0.1%+8.9%+13.5%+4.2%+4.2%+7.2%+2.8%+13.9%+9.9%+9.3%+9.4%-3.6%+19.2%+7.8%+11.1%+10.2%+11.2%
Cost of revenue$1.89B$1.91B$2.17B$2.22B$2.34B$2.79B$2.88B$3.08B$3.45B$3.56B$4.08B$4.54B$5.00B$5.50B$5.60B$6.40B$7.41B$8.00B$8.62B$9.05B
Gross profit$3.51B$4.09B$4.55B$4.50B$4.98B$5.52B$5.78B$5.94B$6.22B$6.39B$7.25B$7.90B$8.60B$9.38B$8.75B$10.71B$11.04B$12.49B$13.98B$16.07B
Gross margin65.0%68.2%67.7%67.0%68.0%66.4%66.7%65.9%64.3%64.2%64.0%63.5%63.2%63.0%61.0%62.6%59.8%61.0%61.9%64.0%
R&D$324.60M$375.30M$367.80M$336.20M$393.90M$462.00M$471.00M$536.00M$614.00M$625.00M$715.00M$787.00M$862.00M$971.00M$905.00M$1.13B$1.23B$1.29B$1.41B$1.58B
SG&A$2.06B$2.39B$2.63B$2.51B$2.71B$3.15B$3.47B$4.07B$3.58B$3.61B$4.14B$4.55B$5.10B$5.36B$5.36B$5.75B$6.04B$7.13B$7.68B$8.22B
Operating income$1.13B$1.33B$1.55B$1.72B$1.85B$1.97B$1.92B$2.10B$2.23B$2.25B$2.58B$2.77B$3.10B$3.39B$3.03B$3.76B$3.73B$4.28B$5.06B$4.89B
Operating margin20.8%22.1%23.1%25.6%25.3%23.7%22.1%23.3%23.0%22.6%22.8%22.2%22.8%22.8%21.1%22.0%20.2%20.9%22.4%19.5%
EBITDA$1.45B$1.76B$2.00B$2.02B$2.22B$2.26B$2.05B$1.61B$1.65B$2.24B$2.69B$2.95B$3.34B$3.63B$3.08B$3.61B$4.02B$5.06B$4.94B$6.31B
EBITDA margin26.7%29.3%29.7%30.1%30.3%27.2%23.7%17.9%17.1%22.5%23.8%23.7%24.6%24.4%21.5%21.1%21.8%24.7%21.9%25.1%
EBIT$1.11B$1.39B$1.61B$1.64B$1.81B$1.78B$1.77B$1.31B$1.27B$1.84B$2.15B$2.31B$2.62B$2.85B$2.27B$2.62B$3.02B$4.03B$3.89B$5.12B
Interest expense$9.50M$22.20M$30.50M$14.50M$77.50M$94.00M$67.00M$95.00M$113.00M$108.00M$228.00M$247.00M$264.00M$287.00M$315.00M$337.00M$337.00M$356.00M$396.00M$607.00M
Income tax$326.10M$383.40M$432.40M$516.50M$456.20M$341.00M$407.00M$206.00M$645.00M$296.00M$274.00M$1.04B$-1.20B$479.00M$355.00M$287.00M$325.00M$508.00M$499.00M$1.27B
Effective tax rate29.5%27.4%27.4%31.8%26.4%20.2%23.9%17.0%55.6%17.1%14.3%50.6%-50.8%18.7%18.2%12.6%12.1%13.8%14.3%28.1%
Net income$777.70M$1.02B$1.15B$1.11B$1.27B$1.34B$1.30B$1.01B$515.00M$1.44B$1.65B$1.02B$3.55B$2.08B$1.60B$1.99B$2.36B$3.17B$2.99B$3.25B
Net income growth (YoY)+30.8%+12.8%-3.5%+15.0%+5.6%-3.5%-22.5%-48.8%+179.4%+14.5%-38.1%+248.3%-41.4%-23.2%+24.7%+18.3%+34.2%-5.4%+8.5%
Profit margin14.4%17.0%17.1%16.5%17.4%16.2%15.0%11.2%5.3%14.5%14.5%8.2%26.1%14.0%11.1%11.7%12.8%15.4%13.2%12.9%

Frequently asked questions

What is Stryker Corporation's revenue?

Stryker Corporation's trailing twelve-month revenue is $25.27B, and consensus projects about $36.89B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is SYK?

In its most recent fiscal year, SYK ran a gross margin of 63.96%, an operating margin of 19.47%, and a net margin of 12.92%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does SYK generate?

SYK produced $4.28B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is SYK's balance sheet healthy?

SYK holds $4.01B in cash and equivalents against $14.86B in long-term debt, on $22.42B of shareholder equity. That debt is best read against the cash flow the business throws off each year.